| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-06 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |